A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care

By Sørensen Jan   Stage Kurt   Damsbo Niels   Lay Agathe Le   Hemels Michiel  

Nordic Journal of Psychiatry, Vol. 61, Iss. 2, 2007-01 ,pp. : 100-108

Informa Healthcare

Access to resources Recommend Favorite

Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder

By Xie Feng   Despiegel Nicolas   Danchenko Natalya   Hansen Karina  

International Journal of Psychiatry in Clinical Practice, Vol. 13, Iss. 1, 2009-03 ,pp. : 59-69

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Escitalopram in the Long-term Treatment of Major Depressive Disorder

By Wade Alan   Despiegel Nicolas   Heldbo Reines Elin  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 2, 2006-05 ,pp. : 83-89

Informa Healthcare

Access to resources Recommend Favorite

Major depressive disorder and response to citalopram treatment in women attending menopause clinic

By Belső Nóra   Kiss Kitty   Rihmer Zoltán   Tüzkő Nándor   Tóth Sándor János   Paulin Ferenc  

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 4, 2003-12 ,pp. : 269-272

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Effectiveness of antidepressants in the treatment of major depressive disorder in Latin America

By Dueñas Héctor J.   Dwight Trisha   McBride Margaret E.   Brnabic Alan J.M.   Semper Luis A.   Holmgren Dagmar   Miranda-Scippa Angela M.A.   Rincón Hernán G.   Aguilera Héctor   Vargas Adrian  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 2, 2007-01 ,pp. : 129-139

Ashgate Publishing Ltd

Access to resources Recommend Favorite